SPOTLIGHT -
Dollar rates
Increase in the incidence rate of conjunctival melanoma in Australia
Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
The European Commission is expected to make a decision about the application before the end of June
An alternative approach to spectacle independence
Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs